EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Identification and Antifungal Susceptibility Patterns of Candida Species in Pediatric Patients at Tabriz Children′s Hospital

Kamran Hosseini iD, Behrooz Naghili Hokmabadi iD, Narges Aslani iD, Taraneh Mirzai iD, Mahdieh Manafi Shabestari, Mohammad Ahangarzadeh Rezaee iD, Mohammad Bagher Hosseini iD, Azita Dilmaghani iD

BioMed Research International · 2026-01 · 2026 (1)

DOI: 10.1155/bmri/6685542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 05.06.2026. Verfasst von Kamran Hosseini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir. Hauptthemen laut MEDLINE: Antifungal Agents, Candida, Candidiasis. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida species are significant opportunistic pathogens, particularly in immunocompromised pediatric populations. With the increasing incidence of invasive candidiasis in neonatal and pediatric intensive care units, accurate species identification and antifungal susceptibility profiling have become critical for effective treatment. This dual‐phase study is aimed at: (1) identifying Candida species from clinical samples using conventional and molecular methods (rDNA‐ITS sequencing), and (2) evaluating antifungal susceptibility patterns against fluconazole, itraconazole, amphotericin B, and caspofungin. A total of 97 clinical isolates were obtained from pediatric patients for molecular identification, with 67 isolates successfully subcultured and evaluated for antifungal susceptibility testing. Species identification involved culture on selective media, microscopic examination, DNA extraction, and ITS region sequencing. Antifungal susceptibility testing was performed using the broth microdilution method (CLSI M27 standard) with RPMI‐1640 medium, incubating at 35°C for 48 h. Minimum inhibitory concentration (MIC) endpoints were determined visually. Molecular identification revealed the following distribution: C. glabrata (50 isolates, 51.5%), C. albicans / dubliniensis complex (34, 35.1%), C. kefyr (5, 5.2%), C. krusei (6, 6.2%), and C. tropicalis (2, 2.1%). Susceptibility testing showed widespread resistance to fluconazole (particularly in C. glabrata , C. albicans , and C. krusei ) and amphotericin B; variable resistance to itraconazole (with 100% susceptibility in C. kefyr ); and universal susceptibility to caspofungin (97.4%–100% across species). Our findings highlight a concerning epidemiological shift toward nonalbicans species, predominantly C. glabrata , with distinct resistance profiles. While caspofungin remains highly effective, the observed resistance patterns underscore the necessity of routine antifungal susceptibility testing to guide therapy and prevent treatment failure in pediatric candidiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidaCandidiasisHumansMicrobial Sensitivity TestsChildChild, PreschoolCaspofunginItraconazoleDrug Resistance, FungalAmphotericin BFluconazoleInfantHospitals, PediatricMaleFemaleLipopeptides

Stichwörter der Autor:innen

C. albicansCandida speciesITS sequencingantifungal susceptibilitybroth microdilutiondrug resistancepediatric candidiasis

Substanzen

Antifungal AgentsCaspofunginItraconazoleAmphotericin BFluconazoleLipopeptides

Autor:innen und Institutionen

  • Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
  • Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.
  • Department of Parasitology and Mycology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran, umsu.ac.ir.
  • Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran, tbzmed.ac.ir.
  • Pediatric Health Research Center, Tabriz University of Medical Science, Tabriz, Iran, tbzmed.ac.ir.

ORCID-Profile: Kamran Hosseini, Behrooz Naghili Hokmabadi, Narges Aslani, Taraneh Mirzai, Mohammad Ahangarzadeh Rezaee, Mohammad Bagher Hosseini, Azita Dilmaghani

Zitieren

APA

Hosseini, K., Hokmabadi, B. N., Aslani, N., Mirzai, T., Shabestari, M. M., Rezaee, M. A., Hosseini, M. B., & Dilmaghani, A. (2026). Molecular Identification and Antifungal Susceptibility Patterns of Candida Species in Pediatric Patients at Tabriz Children′s Hospital. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/6685542

Vancouver

Hosseini K, Hokmabadi BN, Aslani N, Mirzai T, Shabestari MM, Rezaee MA, et al. Molecular Identification and Antifungal Susceptibility Patterns of Candida Species in Pediatric Patients at Tabriz Children′s Hospital. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/6685542

BibTeX
@article{Hosseini2026,
  author = {Hosseini, Kamran and Hokmabadi, Behrooz Naghili and Aslani, Narges and Mirzai, Taraneh and Shabestari, Mahdieh Manafi and Rezaee, Mohammad Ahangarzadeh and Hosseini, Mohammad Bagher and Dilmaghani, Azita},
  title = {Molecular Identification and Antifungal Susceptibility Patterns of Candida Species in Pediatric Patients at Tabriz Children′s Hospital},
  journal = {BioMed Research International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/bmri/6685542}
}
Kostenlos starten →